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Abstract Recent studies have indicated that biosurfactants
play a role both in maintaining channels between multicellular
structures in biofilms and in dispersal of cells from biofilms. A
combination of caprylic acid (0.01 % v/v) together with
rhamnolipids (0.04 % v/v) was applied to biofilms of
Pseudomonas aeruginosa ATCC 15442, Staphylococcus
aureus ATCC 9144 and a mixed culture under BioFlux
flowthrough conditions and caused disruption of the biofilms.
The biofilms were also treated with a combination of
rhamnolipids (0.04 % v/v) and sophorolipids (0.01 %).
Control treatments with PBS 1× had no apparent effect on
biofilm disruption. The Gram-positive bacterium (S. aureus
ATCC 9144) was more sensitive than P. aeruginosa ATCC
15442 in terms of disruption and viability as shown by Live/
Dead staining. Disruption of biofilms of P. aeruginosa ATCC
15442 was minimal. Oxygen consumption by biofilms, after
different treatments with biosurfactants, confirms that
sophorolipid on its own is unable to kill/inhibit cells of
P. aeruginosa ATCC 15442, and even when used in combi-
nation with rhamnolipids, under static conditions, no decrease
in the cell viability was observed. Cells in biofilms exposed to
mono-rhamnolipids (0.04 % v/v) showed behaviour typical of
exposure to bacteriostatic compounds, but when exposed to
di-rhamnolipids (0.04 % v/v), they displayed a pattern charac-
teristic of bactericidal compounds.
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Introduction
Deposition of microorganisms on solid surfaces and subse-
quent biofilm formation are phenomena that happen naturally
but are also part of the microorganisms’ strategy to protect
themselves from external toxic factors. Intercellular signal-
ling, often referred to as quorum sensing, has been shown to
be involved in biofilm development by several bacteria, in-
cluding Pseudomonas aeruginosa, Burkholderia cepacia,
Streptococcus mutans, and others (Yarwood et al. 2004).
P. aeruginosa biofilms have been extensively studied due to
their relative ease of formation under various conditions in
vitro, their medical importance and the genetic tractability of
the organism involved (Irie et al. 2005). In addition, infec-
tions caused by community-acquired (CA) methicillin-
resistant S. aureus (MRSA) have been reported worldwide.
Such infections pose a serious problem frequently in hos-
pitalized patients and healthcare personnel. Although many
anti-staphylococcal antibiotics have been developed, treat-
ment options for MRSA infections are limited as a result of
the emergence of antibiotic resistance (Samadi et al. 2012).
Biosurfactants of microbial origin have been reported to
have antiadhesive and biofilm disruption abilities (Banat et
al. 2014). In recent years, rhamnolipids derived from
P. aeruginosa have emerged as an important group of
biosurfactants with several applications (Marchant and Banat
2012a, b); they have also been produced on a commercial
scale (Dusane et al. 2010). During the later stages of
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P. aeruginosa biofilm development, the production of the
biosurfactant rhamnolipids was shown to be important in
modulating microcolony architecture by maintaining chan-
nels to allow fluids to flow through the biofilm. However,
the mechanisms by which the bacteria maintain these chan-
nels once they form have not been investigated. Davey et
al. (2003) indicated that P. aeruginosa not only regulates
development of its distinctive biofilm architecture but also,
once channels form, this organism utilizes rhamnolipid
surfactants to actively maintain the void spaces surround-
ing macrocolonies; in other words, they propose that
rhamnolipids are not required for the formation of
macrocolonies and channels but participate in the mainte-
nance of channels once they are formed.
Antimicrobial properties are not restricted just to
rhamnolipids, biosurfactants produced by Lactobacilli;
other strains have also been shown to reduce adhesion of
pathogenic micro-organisms to glass, silicone rubber and
surgical implants (Fracchia et al. 2010; Quinn et al. 2013).
Therefore, prior adsorption of biosurfactants can be used as
a preventive strategy to delay the onset of pathogenic
biofilm growth on catheters and other medical materials,
reducing the use of synthetic drugs and chemicals. Another
possible strategy to reduce the global problem of antimi-
crobial resistance is the combination of two or more com-
pounds together, which has been used in recent years
(Samadi et al. 2012). In this continuing search for new
combinations of natural products as antimicrobial agents,
we found that biosurfactants produced by P. aeruginosa in
combination with caprylic acid have potential activity
aga ins t p r e - fo rmed b io f i lms o f S . aureus and
P. aeruginosa. We also investigated the effects mono-
rhamnolipids and di-rhamnolipids have on P. aeruginosa
cells in biofilms.
Materials and methods
Microorganisms and culture conditions
P. aeruginosa ATCC 15442 and S. aureus ATCC 9144 were
acquired from the American Type Culture Collection (ATCC).
The strains were maintained in nutrient broth plus 20 % glyc-
erol at −20 °C. Bacterial growth from a nutrient agar slant
incubated for 24 h at 30 °C was used to obtain a bacterial
suspension with an optical density at 570 nm adjusted to give
108 CFU/mL.
Rhamnolipids characteristics
The rhamnolipid containing 10 % (w/v) mono-rhamnolipid
(C26H48O9, MW 504, critical micelle concentration (CMC)
20 mg/L M at neutral pH) and 10 % (w/v) di-rhamnolipid
(C32H58O13, MW 650, CMC 1.5 × 10
−4 30 mg/L at neutral
pH) was obtained from Jeneil Biosurfactant Co. (Saukville,
WI, USA). Mono-rhamnolipids and di-rhamnolipids were ob-
tained as described by Rudden et al. (2015) and kept refriger-
ated at 4 °C until further use.
Sophorolipid characteristics
The sophorolipid SL18 containing 50 % hydrophile
(sophorose) plus 50 % lipophile (fatty acid), with density
1.1 ± 0.1, a water activity 35 ± 5 %, surface tension 38 mN/
m, and CMC 40 mg/L, was obtained from ECOVER
(Newbury-Berkshire, UK).
Biofilm growth on the BioFlux flowthrough device
To analyze biofilm formation under flow conditions, the
BioFlux 200 system (Fluxion Biosciences Inc., South San
Francisco, CA) was used which allows automated image
acquisition within specialized multiwell plates. To grow
biofilms, the microfluidic channels (depth, 75 μm; width,
350 μm) were primed with TSB (50 %) at 10.0 dyn/cm2.
Channels were seeded with 107 CFU from an overnight
culture of P. aeruginosa ATCC 15442, S. aureus ATCC
9144 and a mixed culture of both. The plate was then in-
cubated at 30 °C for 48 h to allow cells to adhere. After
biofilms had formed, planktonic cells were removed, and
PBS 1× (as control) and different treatments were added to
the input wells at a flow rate of 279 μL/h for 30 min. The
results were recorded with a microscope Evon (×10) (17 %
light).
Growth of Bstatic^ biofilms on OxoPlates®
P. aeruginosa ATCC 15442 was grown overnight as pre-
viously described and diluted 100-fold with TSB 50 %
following which a 100-μL sample of each diluted culture
was dispensed (eight replicates) to fill a 96-well OxoPlate
OP96C®. After 48 h, each well was rinsed twice with PBS
1×S, and the active different treatments were added to each
well during 30 min at 30 °C. OxoPlate OP96C (PreSens,
Regensburg, Germany) contains oxygen-sensitive particles
PSLi-Pt-1 (Opto-Sense, Wörth, Germany), which consist
of small polystyrene particles. The sensor has a thickness
of about 10 μm and is fixed at the bottom of each well of a
96-flat bottom-well plate (Greiner, Frickenhausen,
Germany). The oxygen concentration in each well was
followed for 21 h at 20-min intervals. Fluorescence of each
well was measured in dual kinetic mode (BMG Labtech
GmbH, Germany). Filter pair 1 (544/650 nm) detects fluo-
rescence of the indicator dye. The second filter pair (544/
590 nm) measures fluorescence of the reference dye.
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All experiments were repeated on separate days. Oxygen
concentration as percentage air saturation was calculated for
each well by using the following equation :
pO2 ¼ 100 
k0
IR
−1
 
=
k0
k100
−1
 
Results
Biofilm disruption of P. aeruginosa ATCC 15442,
S. aureus ATCC 9144 and a mixed culture using
rhamnolipids and caprylic acid
The effect of rhamnolipids together with caprylic acid on pre-
formed biofilms by P. aeruginosa ATCC 15442, S. aureus
ATCC 9144 and a mixed culture was determined under
BioFlux flowthrough conditions. The disruption produced
by the combination of caprylic acid together with
rhamnolipids was confirmed. All isolates developed biofilms
over 48 h. However, there was considerable variability in
terms of spread around of the microfluidic channel.
P. aeruginosa biofilms and the mixed culture were well
formed (Fig 1a, e, g) under flow conditions; however, the
biofilms formed by S. aureus ATCC 9144 (Fig. 1c) were not
as thick, but good enough to be considered a multicellular
community that represented a fundamentally different physi-
ological state compared to free-living planktonic bacteria.
After 48 h, all the plates were rinsed with PBS 1× (a
water-based salt solution in which the osmolarity and ion
concentrations of the solution) as a control, and the treat-
ment combinations of rhamnolipids (0.04 % v/v) and
caprylic acid (0.01 % v/v) were applied for 30 min, after
which period more than the 90 % disruption of the biofilms
had occurred. It is interesting to note that P. aeruginosa
ATCC 15442 and S. aureus ATCC 9144 respond different-
ly to the combination between rhamnolipids and caprylic
acid, compared to individual application (Dusane et al.
2010, Dusane et al. 2012), suggesting a possible interac-
tion between rhamnolipids and caprylic acid.
Effect of rhamnolipids and sophorolipids on biofilm
disruption of P. aeruginosa ATCC 15442, S. aureus ATCC
9144 and a mixed culture
Previous studies have shown that rhamnolipids can bring
about disruption of pre-formed biofilms of P. aeruginosa
and S. aureus and indicate that sophorolipids have potential
to be used individually for efficient removal and killing of
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Fig. 1 Biofilm formation and disruption in a BioFlux channel. The
images are phase-contrast images and show fully formed biofilms after
48 h of incubation at 30 °C, and the images were recorded with a
microscope Evon (10×) (17 % light). a P. aeruginosa ATCC 15442
biofilm before treatment. b P. aeruginosa ATCC 15442 after treatment
with rhamnolipid (0.04 %) and caprylic acid (0.01 %). c S. aureusATCC
9144 before treatment. d S. aureus ATCC 9144 after treatment with
rhamnolipid (0.04 %) and caprylic acid (0.01 %). e Mixed culture
(P. aeruginosaATCC15442/S. aureusATCC 9144). fMixed culture after
treatment with rhamnolipid (0.04 %) and caprylic acid (0.01 %). g
P. aeruginosa ATCC 15442 before treatment. h P. aeruginosa ATCC
15442 after treatment with PBS 1×
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detrimental biofilms formed by Bacillus subtilis (Díaz De
Rienzo et al. 2015a). To investigate different combinations
between natural compounds for the treatment of infections
caused bymultidrug-resistant bacteria, we used a combination
between rhamnolipids and sophorolipids for the disruption/
killing of preformed biofilms of P. aeruginosa ATCC 15442
and S. aureus ATCC 9144.
The treatment of the all the biofilms with PBS 1× had no
apparent effects on the biofilm, and all the cells were well
established and viable (Fig. 2a, c, e). The Gram-positive bac-
terium S. aureus ATCC 9144 was more sensitive to the com-
bination of rhamnolipids and sophorolipids (Fig 2d) than
P. aeruginosa ATCC 15442 (Fig. 2b), not just in terms of
the disruption but in terms of viability as shown by
LIVE/DEAD staining. Interestingly, biofilm disruption of
S. aureus ATCC 9144 and the mixed culture was apparently
not caused by the reported bactericidal activity of
rhamnolipids or sophorolipids, because the majority of the
remaining attached cells (Fig. 2d, f) were viable (green
stained). On the other hand, the disruption of biofilms of
P. aeruginosa ATCC 15442 (Fig. 2B) was minimal; after
30 min of treatment, just a few cells were detached as shown
by the images before and after treatment. However, the re-
maining cells were stained red, which indicated that this com-
bination at the concentrations evaluated is not effective in
removing the cells but is effective in killing them. This could
mean that the combination between rhamnolipids (0.04 %)
and sophorolipids (0.01 %) may be used as a specific strategy
to kill cells within biofilms of P. aeruginosa ATCC 15442
within a period on 30 min.
Effect of different biosurfactants on oxygen consumption
by biofilms of P. aeruginosa ATCC 15442
Biofilms of P. aeruginosa ATCC 15442 were formed on an
OxoPlate® after 48 h at 30 °C; once the biofilms were rinsed
with PBS 1× twice, they were incubated for half an hour under
different treatments (Table 1).
A minimum number of cells were required to consume a
threshold amount of oxygen before they were detected in
the system. All the results shown in Fig. 3a are above this
threshold due to a high inoculum density; as a conse-
quence, consumption of oxygen was detected immediately
and the growth medium was essentially free of oxygen
after 1 h, for all treatments used. These results confirm that
sophorolipids on their own are unable to kill or inhibit
oxygen uptake by cells of P. aeruginosa ATCC 15442,
and even in combination with rhamnolipids, under static
conditions, no decrease in the cell metabolism was
observed.
As described above, oxygen consumption was quanti-
fied for different treatments including mono- and di-
rhamnolipids separately at 0.04 % v/v. In Fig. 3b, the
curves also give insight into the kinetics of bacterial
growth inhibition. The cells with mono-rhamnolipid treat-
ment showed a delay of oxygen consumption during the
first 2 h of active growth; however, the oxygen level in
each well declined gradually to 0 % and stayed at this
level, behaviour typical of bacteriostatic compounds. On
the other hand, the cells treated with di-rhamnolipids
displayed a strikingly dissimilar pattern, because of the
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Fig. 2 Effect of rhamnolipids and sophorolipids on Biofilm disruption.
Biofilms were grown for 48 h at 30 °C and then stained with Live/Dead
BacLight and the images were recorded with a microscope Evon (×10)
(17 % light). a P. aeruginosa ATCC 15442 biofilm before treatment. b
P. aeruginosa ATCC 15442 after treatment with rhamnolipid (0.04 %)
and sophorolipid (0.01 %). c S. aureus ATCC 9144 before treatment. d
S. aureus ATCC 9144 after treatment with rhamnolipid (0.04 %) and
sophorolipid (0.01 %). e Mixed culture (P. aeruginosa ATCC 15442/
S. aureus ATCC 9144). fMixed culture after treatment with rhamnolipid
(0.04 %) and sophorolipid (0.01 %)
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initial effect after the treatment when the oxygen concen-
tration increased. This increase is attributable to the en-
hanced diffusion of atmospheric oxygen into the wells af-
ter cell death, which is an indication that we are dealing
with a bactericidal compound.
Discussion
Understanding the complex way that bacteria colonize and
build specialized structures like biofilms and formulating
new strategies to deal with their formation or facilitate their
disruption through removal or killing are current issues in
medical and industrial microbiology. One of the possible
solutions for this global problem is the appropriate use of
antimicrobial combinations (Menichetti 2005). The results
of biofilm disruption of P. aeruginosa ATCC 15442,
S. aureus ATCC 9144 and a mixed culture using
rhamnolipids and caprylic acid showed that this strategy
is effective under flow cell conditions, not just for cell
removal but also for killing most of the cell population
(data not shown). This is true for either P. aeruginosa
ATCC 15442, S. aureus ATCC 9144 or a mixed culture
of both, despite the fact that most bacterial biofilms display
resistance against antimicrobials such as antibiotics and
various host immune responses (Jesaitis et al. 2003).
Table 1 Biosurfactant treatments applied prior to the measurement of
the oxygen consumption of biofilms of Pseudomonas aeruginosa ATCC
15442
Treatment Concentration (v/v)a
PBS 1× –
Sophorolipids 0.01 %
Rhamnolipids/sophorolipids 0.04 %/0.01 %
Mono-rhamnolipids 0.04 %
Di-rhamnolipids 0.04 %
aAll concentrations used are above the critical micelle concentrations for
these biosurfactants
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Rhamnolipids are secreted by P. aeruginosa and are in-
volved in biofilm formation through the promotion of motility,
the inhibition of attachment and the degradation of the matrix
maintaining channels throughout the biofilm for movement of
water and oxygen (Banat et al. 2014); however, when the bio-
film is already formed, the external addition of rhamnolipids
could be involved in the removal of extracellular polymeric
substances (EPS) and destruction of microcolonies altering the
biofilm environment as a result of their surface active properties,
in addition to a generalized activity of altering charge-charge
properties (Davey et al. 2003), which may decrease the chances
for the bacteria to acquire resistance due to spontaneous muta-
tions. In this report, the combination between rhamnolipids and
caprylic acid induced disruption of mature biofilms of
P. aeruginosaATCC 15442, S. aureusATCC 9144 and amixed
culture, despite the fact that most of the P. aeruginosa ATCC
15442 cells were alive, showing that the primary effect of this
combination does not appear to be bactericidal.
The use of rhamnolipids with other biosurfactants may
have a strong ability to disrupt biofilm structures, in the same
way that was already shown for combination with antibiotic
treatments (Samadi et al. 2012). In this study, we show that the
combination between rhamnolipids and sophorolipids could
be useful to remove cells of S. aureusATCC 9144 and amixed
culture between them, previously attached to a polymeric sur-
face. Nevertheless, when we consider the effect on biofilms of
P. aeruginosa ATCC 15442, the effect of this combination is
different, due to the fact that most of the cells were dead after
the treatment. The combination between rhamnolipids and
sophorolipids at the concentration evaluated in this work
might be used as a specific strategy to kill or eliminate
biofilms ofP. aeruginosaATCC 15442 under flow conditions,
while the bioactivity and possible synergistic interactions and
effect between these biosurfactant need to be further
investigated.
The mechanism for bioactivity of biosurfactants is sug-
gested to be associated with their intercalation into target cell
membranes. Samadi et al. (2012) demonstrated that
rhamnolipids (as a mixture of mono and di forms) and
mono-rhamnolipids and di-rhamnolipids separately were
more effective against Gram-positive than Gram-negative
bacteria such as P. aeruginosa when they are growing in the
planktonic form, due to the fact that the lipopolysaccharide
(LPS) present in the outer membrane increases the negative
charge of the cell membrane and its lipid portion is imperme-
able to the charged rhamnolipids. Several methods are in use
to quantify bacterial growth in the presence or absence of
antibacterial compounds, to study planktonic and biofilm be-
haviour of diverse populations of cells. Here we used a fluo-
rescence assay system that quantifies the oxygen concentra-
tion in the growth medium called OxoPlates®. This study
showed how mono- and di-rhamnolipids have an antimicro-
bial effect on biofilms by P. aeruginosa ATCC 15442,
measured as a decrease of oxygen concentration over time
(Fig. 3a, b) on OxoPlates®; however, the effect of
rhamnolipids, a mixture of mono and di forms, was not eval-
uated on oxoplates but they were confirmed as potential
disruptors in previous experiments (Díaz De Rienzo et al.
2015b).
The cells treated with mono-rhamnolipids and di-
rhamnolipids showed different mechanisms of action.
Mono-rhamnolipids act as bacteriostatic compounds, and the
effect of di-rhamnolipids is bactericidal as indicated by the
response that we observed in Fig. 3b, related to oxygen con-
sumption. Rhamnolipids are biologically produced com-
pounds and assumed to be biocompatible and safe for human
use; recent investigations by our group at Ulster University
showed that acidic sophorolipids induced a dose-dependent
decrease in cell viability of colorectal cancer cell lines without
affecting the viability of the colonic epithelial and lung cell
lines (Callaghan et al. 2015). However, their effects in vivo are
yet to be established. Research is therefore undergoing to test
the different effects of selected rhamnolipid congeners on both
normal and cancer cell lines.
Further studies should focus on the action of different nat-
ural rhamnolipids either alone or in combination with other
compounds like antibiotics or enzymes which play an impor-
tant role in the stability of the EPS during biofilm formation
(Meers et al. 2008). This may open a new approach to combat
the establishment or possible disruption of biofilm formation
by different bacterial species through disruption of adhesion or
growth of coated medical and industrial instruments, for exam-
ple. It would however be important to take into account that
combinations with other compounds described above may be-
have differently for particular species. In this study, we have
confirmed the biofilm disruption of P. aeruginosa ATCC
15442, S. aureus ATCC 9144 and a mixed culture using
rhamnolipids and caprylic acid, as well as the greater sensiti-
vity of S. aureus ATCC 9144 over P. aeruginosa in terms of
disruption and viability as shown by Live/Dead staining. In
addition, a combination of rhamnolipids and sophorolipids
might be used as a specific strategy to eliminate biofilm of
P. aeruginosa ATCC 15442 under flow conditions, as a result
of a bacteriostatic or bactericidal mechanism of action.
Acknowledgments The authors acknowledge the assistance of Ms.
Joanne O’Keefe (Unilever, Port Sunlight) with the BioFlux experiments;
her guidance and knowledge were key in the performance of the exper-
iments. We also acknowledge Jeneil Biosurfactant for providing
rhamnolipid samples and ECOVER for providing sophorolipid samples.
Compliance with ethical standards This article does not contain
any studies with human participants or animals performed by any
of the authors.
Funding This study was funded by Unilever, Port Sunlight, UK.
Appl Microbiol Biotechnol
Conflict of interest The authors declare that they have no competing
interests; the results of this work have already been made available to
Unilever.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
References
Banat IM, Diaz De Rienzo MA, Quinn GA (2014) Microbial biofilms:
biosurfactants as antibiofilm agents. Appl Microbiol Biotechnol
98(24):9915–9929
Callaghan B, Roelants S, Baccile N, Lydon H, Van Bogaert I, Banat IM,
Marchant R, Mitchell CA (2015) Sophorolipid-mediated inhibition
of colorectal tumor cell growth in vitro and in vivo Cancer Res
75(15):Abstract nr 2294. doi:10.1158/1538–7445.AM2015-2294
Davey ME, Caiazza NC, O'Toole GA (2003) Rhamnolipid surfactant
production affects biofilm architecture in Pseudomonas aeruginosa
PAO1. J Bacteriol 185:1027–1036
Díaz De Rienzo MA, Banat IM, Dolman B, Winterburn J, Martin P
(2015a) Sophorolipid biosurfactants: possible uses as antibacterial
and antibiofilm agent. New Biotechnol 32(6):720–726
Díaz De Rienzo MA, Stevenson P, Marchant R, Banat IM (2015b)
Antibacterial properties of biosurfactants against selected gram pos-
itive and negative bacteria. FEMS Microbiol Lett. doi:10.1093/
femsle/fnv224
Dusane DH, Nancharaiah YV, Zinjarde SS, Venugopalan VP (2010)
Rhamnolipid mediated disruption of marine Bacillus pumilus
biofilms. Colloids Surfaces B Biointerfaces 81:242–248
Dusane DH, Dam S, Nancharaiah YV, Kumar AR, Venugopalan VP,
Zinjarde SS (2012) Disruption of Yarrowia lipolytica biofilms by
rhamnolipid biosurfactant. Aquatic Biosystems 8(1):17
Fracchia L, Cavallo M, Allegrone G, Martinotti MG (2010) A
Lactobacillus-derived biosurfactant inhibits biofilm formation
of human pathogenic Candida albicans biofilm producers in
Current Research, Technology and Education Topics in
Applied Microbiology and Microbial Biotechnology, ed. A.
Méndez-Vilas, Volume II edn, Formatex Research Center,
Badajoz, Spain, pp. 827–837
Irie Y, O'Toole GA, Yuk MH (2005) Pseudomonas aeruginosa
rhamnolipids disperse Bordetella bronchiseptica biofilms. FEMS
Microbiol Lett 250:237–243
Jesaitis AJ, Franklin MJ, Berglund D, Sasaki M, Lord CI, Bleazard
JB, Duffy JE, Beyenal H, Lewandowski Z (2003) Compromised
host defense on Pseudomonas aeruginosa biofilms: characteri-
zation of neutrophil and biofilm interactions. J Immunol 171:
4329–4339
Marchant R, Banat IM (2012a) Biosurfactants: a sustainable replacement
for chemical surfactants? Biotechnol Lett 34:1597–1605
Marchant R, Banat IM (2012b) Microbial biosurfactants: challenges
and opportunities for future exploitation. Trends in Biotechnol
30:558–565
Meers P, Neville M, Malinin V, Scotto AW, Sardaryan G, Kurumunda R,
Mackinson C, James G, Fisher S, Perkins WR (2008) Biofilm pen-
etration, triggered release and in vivo activity of inhaled liposomal
amikacin in chronic Pseudomonas aeruginosa lung infections. J
Antimicrobial Chemotherapy 61:859–868
Menichetti F (2005) Current and emerging serious Gram-positive infec-
tions. Clinical Microbiology Infection 11(Suppl 3):22–28
Quinn GA, Maloy AP, Banat MM, Banat IM (2013) A comparison of
effects of broad-spectrum antibiotics and biosurfactants on
established bacterial biofilms. Current Microbiol 67:614–623
Samadi N, Abadian N, Ahmadkhaniha R, Amini F, Dalili D, Rastkari N,
Safaripour E, Mohseni FA (2012) Structural characterization and
surface activities of biogenic rhamnolipid surfactants from
Pseudomonas aeruginosa isolate MN1 and synergistic effects
against methicillin-resistant Staphylococcus aureus. Folia
Microbiol 57:501–508
Rudden M, Tsauosi K, Marchant R, Banat IM, Smyth TJ (2015)
Development and validation of an ultra-performance liquid chroma-
tography tandem mass spectrometry (UPLC-MS/MS) method for
the quantitative determination of rhamnolipid congeners. Appl
Microbiol Biotechnol 99:9177–9187
Yarwood JM, Bartels DJ, Volper EM, Greenberg EP (2004) Quorum
sensing in Staphylococcus aureus biofilms. J Bacteriol 186:
1838–1850
Appl Microbiol Biotechnol
